Piribo

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a report which provides a comprehensive analysis of the Global Cardiovascular Device Markets 2007-2012.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report which provides an in-depth review of reimbursement issues for medical devices in 27 European markets.

Piribo has added a new report which offers invaluable information for those searching for an easy way to construct effective clinical trials for medical devices in the EU.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report providing a comprehensive analysis of the global market for in-vitro diagnostics (IVD).

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report offering a comprehensive financial analysis of the global medical technology industry.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a report added a report analysing the current situation in India's medical technology market.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a report on bio-device licensing which assesses the critical success factors in drug and device collaborations.

Piribo has now added a report featuring detailed profiles of ventured backed start-ups and fast-growing American and European companies which are developing technologies for improving patient healthcare.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on investment opportunities in drug delivery in Spain.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report that forecasts the global wound care market will see double digit growth to 2012.